Finding Alzheimer's earliest signature in memory concerns
Part of Brain & nervous system clinical trials.
This study looks for early signs of Alzheimer's in people who feel their memory is slipping but still function normally. You'll help researchers find a pattern—a 'signature'—in the brain that may signal the earliest stages of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have memory concerns that bother you but are not severe enough for a dementia diagnosis.
- You score above 24 on a standard memory test (adjusted for age and education).
- You can manage your daily activities (like dressing, bathing, handling money) without help.
- You have no history of head injury with loss of consciousness.
- You do not have other brain or serious body illnesses (like prior stroke, Parkinson's, or major depression).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests strategies to prevent Alzheimer's disease in people with early memory concerns. It may help if you notice your thinking is not as sharp as before, but you can still manage daily tasks on your own.
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
This study evaluates a new computer-based test to detect early memory and thinking changes before they progress to dementia. Researchers are looking for adults 65+ who've noticed subtle cognitive changes in the last 5 years to help refine and test this assessment tool.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study uses brain scans, blood tests, and genetic information to find early signs of Alzheimer's disease before memory problems start. It aims to predict who might develop Alzheimer's in the future.
Hear when a new Subjective Cognitive Decline (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.